SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Enzhu Jiang, Fengrui Li, Chenchen Jing, Pei Li, Honggang Cui, Baojie Wang, Mei Ding, Hao Pang, High-Resolution Melting Analysis as a Developed Method for Genotyping the PD Susceptibility Loci in LRRK2 Gene, Journal of Clinical Laboratory Analysis, 2015, 29, 2
  2. 2
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  3. 3
    Ryan D. Mills, Terrence D. Mulhern, Fei Liu, Janetta G. Culvenor, Heung-Chin Cheng, Prediction of the Repeat Domain Structures and Impact of Parkinsonism-Associated Variations on Structure and Function of all Functional Domains of Leucine-Rich Repeat Kinase 2 (LRRK2), Human Mutation, 2014, 35, 4
  4. 4
    Dariusz Koziorowski, Dorota Hoffman-Zacharska, Jarosław Sławek, Zygmunt Jamrozik, Piotr Janik, Anna Potulska-Chromik, Anna Roszmann, Renata Tataj, Jerzy Bal, Andrzej Friedman, Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients, Neurologia i Neurochirurgia Polska, 2013, 47, 4, 319

    CrossRef

  5. 5
    Emmy H. Rannikko, Louise Buur Vesterager, Jafar H. A. Shaik, Stephanie S. Weber, Elena M. Cornejo Castro, Karina Fog, Poul H. Jensen, Philipp J. Kahle, Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion, Journal of Neurochemistry, 2013, 125, 2
  6. 6
    Shahrul Azmin, Abdul Manaf Khairul Anuar, Wan Yahya Nafisah, Hui Jan Tan, Azman Ali Raymond, Othman Hanita, Shamsul Azhar Shah, Mohamed Ibrahim Norlinah, Restless Legs Syndrome and Its Associated Risk Factors in Parkinson’s Disease, Parkinson's Disease, 2013, 2013, 1

    CrossRef

  7. 7
    Yoshikuni Mizuno, An update on the management of juvenile and young-onset Parkinson’s disease, Future Neurology, 2012, 7, 5, 581

    CrossRef

  8. 8
    Ilse S. Pienaar, David Burn, Christopher Morris, David Dexter, Synaptic Protein Alterations in Parkinson’s Disease, Molecular Neurobiology, 2012, 45, 1, 126

    CrossRef

  9. 9
    Eng-King Tan, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  10. 10
    Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L. Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi, Thomas J. Ruth, Chong S. Lee, Donald B. Calne, A. Jon Stoessl, Age-specific progression of nigrostriatal dysfunction in Parkinson's disease, Annals of Neurology, 2011, 69, 5
  11. 11
    Peter Elfferich, Marja C. Verleun-Mooijman, J. Anneke Maat-Kievit, Bart P. C. van de Warrenburg, Wilson F. Abdo, Sylvia A. Eshuis, Klaus L. Leenders, Ad Hovestadt, Jan C. M. Zijlmans, Jan-Pieter M. Stroy, John C. van Swieten, Agnita J. W. Boon, Klaartje van Engelen, Corien C. Verschuuren-Bemelmans, Saskia A. J. Lesnik-Oberstein, Cristina Tassorelli, Leonardo Lopiano, Vincenzo Bonifati, Dennis Dooijes, Rick van Minkelen, Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations, neurogenetics, 2011, 12, 4, 263

    CrossRef

  12. 12
    Stephanie M. van Rooden, Fabrice Colas, Pablo Martínez-Martín, Martine Visser, Dagmar Verbaan, Johan Marinus, Ray K. Chaudhuri, Joost N. Kok, Jacobus J. van Hilten, Clinical subtypes of Parkinson's disease, Movement Disorders, 2011, 26, 1
  13. 13
    Christine Klein, Ana Djarmati, Parkinson disease: Genetic testing in Parkinson disease—who should be assessed?, Nature Reviews Neurology, 2011, 7, 1, 7

    CrossRef

  14. 14
    David Crosiers, Jessie Theuns, Patrick Cras, Christine Van Broeckhoven, Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes, Journal of Chemical Neuroanatomy, 2011, 42, 2, 131

    CrossRef

  15. 15
    Conceição Bettencourt, Cristina Santos, Paula Coutinho, Patrizia Rizzu, João Vasconcelos, Teresa Kay, Teresa Cymbron, Mafalda Raposo, Peter Heutink, Manuela Lima, Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report, BMC Neurology, 2011, 11, 1, 131

    CrossRef

  16. 16
    Hee Jin Kim, Han-Joon Kim, Jee-Young Lee, Ji Young Yun, So Yeon Kim, Sung Sup Park, Beom S. Jeon, Phenotype analysis in patients with early onset Parkinson’s disease with and without parkin mutations, Journal of Neurology, 2011, 258, 12, 2260

    CrossRef

  17. 17
    Farzaneh Ghazavi, Zeinab Fazlali, Setareh Sadat Banihosseini, Sayed-Rzgar Hosseini, Mohammad Hossein Kazemi, Seyedmehdi Shojaee, Khosro Parsa, Homa Sadeghi, Farzad Sina, Mohammad Rohani, Gholam-Ali Shahidi, Nasser Ghaemi, Mostafa Ronaghi, Elahe Elahi, PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations, Movement Disorders, 2011, 26, 1
  18. 18
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  19. 19
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  20. 20
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  21. 21
    C. P. Ramsey, E. Tsika, H. Ischiropoulos, B. I. Giasson, DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human  -syn toxicity, Human Molecular Genetics, 2010, 19, 8, 1425

    CrossRef

  22. 22
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  23. 23
    Chenere P. Ramsey, Benoit I. Giasson, Identification and characterization of a novel endogenous murine parkin mutation, Journal of Neurochemistry, 2010, 113, 2
  24. 24
    Chenere P. Ramsey, Benoit I. Giasson, L10p and P158DEL DJ-1 mutations cause protein instability, aggregation, and dimerization impairments, Journal of Neuroscience Research, 2010, 88, 14
  25. 25
    Roy N. Alcalay, Helen Mejia-Santana, Ming X. Tang, Brian Rakitin, Llency Rosado, Barbara Ross, Miguel Verbitsky, Sergey Kisselev, Elan D. Louis, Cynthia L. Comella, Amy Colcher, Danna Jennings, Martha A. Nance, Susan Bressman, William K. Scott, Caroline Tanner, Susan F. Mickel, Howard F. Andrews, Cheryl H. Waters, Stanley Fahn, Lucien J. Cote, Steven J. Frucht, Blair Ford, Michael Rezak, Kevin Novak, Joseph H. Friedman, Ronald Pfeiffer, Laura Marsh, Bradley Hiner, Andrew Siderowf, Ruth Ottman, Lorraine N. Clark, Karen S. Marder, Elise Caccappolo, Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease, Journal of Clinical and Experimental Neuropsychology, 2010, 32, 7, 775

    CrossRef

  26. 26
    L. Correia Guedes, J.J. Ferreira, M.M. Rosa, M. Coelho, V. Bonifati, C. Sampaio, Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review, Parkinsonism & Related Disorders, 2010, 16, 4, 237

    CrossRef

  27. 27
    V. Bonifati, Encyclopedia of Movement Disorders, 2010,

    CrossRef

  28. 28
    Philipp J. Kahle, Jens Waak, Thomas Gasser, DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders, Free Radical Biology and Medicine, 2009, 47, 10, 1354

    CrossRef